1.
Capital Structure Analysis of Chinese Listed Companies of Medicine Industry;
我国医药行业上市公司资本结构分析
2.
Research on the Risk-controlling of Horizontal M&A of List Company in the Pharmaceutical Industry;
医药行业上市公司横向并购风险控制研究
3.
E-Business Application Level Status of Chinese Pharmacy Corporations;
中国医药行业上市公司电子商务应用水平研究
4.
Performance of Listed Companies after Merger & Acquisition in Medical Industry;
我国医药行业上市公司并购绩效的实证研究
5.
The Research of Evaluation on Medicine Industry Listed Companies' Sustainable Growth
医药行业上市公司可持续增长能力的评价研究
6.
Study of Financial Distress Prediction of Our Country's Pharmaceutical Industry Listed Company
我国医药行业上市公司财务危机预警研究
7.
An Empirical Analysis of the Relationship between Ownership Structure and Corporate Performance of Bio-Pharmaceutical Industry Listed Companies;
我国生物医药行业上市公司股权结构与公司绩效关系的实证分析
8.
Financial structure,ownership structure and profitability of the medicinal listed companies in China;
中国医药行业上市公司融资结构、股权结构与公司绩效
9.
Empirical Analysis on Board of Directors Behavior and Performance in Medicine Listed Company;
医药行业上市公司董事会行为与经营绩效实证分析
10.
EVA and Merges & Recombination of Medical Trade Listed Company s Empirical Research;
经济增加值与医药行业上市公司并购重组绩效研究
11.
An Empirical Analysis on Environmental Disclosure of Listed Companies in Chinese Biomedical Industry;
我国医药行业上市公司环境信息披露的实证分析
12.
Evaluation on Relative Efficiency Validity of Medicine Industry Companies Based on Mixed DEA Model;
基于混合DEA模型的医药行业上市公司经营效率相对有效性评价
13.
Research on the Cash Utilizauion Efficiency in Listed Companies based on DEA--Analysis of Biological Medicine Listed Companies in China;
基于DEA的上市公司现金使用效率研究——对我国生物医药行业上市公司的分析
14.
In the capital market, investors are eager to know clearly the management performance of the listed companies in the medicine industry.
在资本市场上,投资者迫切需要对医药行业上市公司有一个清楚的认识。
15.
Analysis of the Market Reaction to Reformation of Stock-splitting in Limited Company-An Empirical Research on Medicine Industry;
上市公司“股权分置”改革市场效应分析——来自医药行业的经验数据
16.
Study on the Financial Performance Measurement of Chinese Pharmaceutical Listed Companies
我国医药制造业上市公司财务业绩评价研究
17.
The Research on Strategic Performance Evaluation of Listed Pharmaceutical Companies
基于战略经营的医药类上市公司业绩评价研究
18.
A Research of the Effect of Capital Structure on Product Market Competition-- Taking the Listed Companies in Pharmaceutical Industry as Examples
资本结构影响产品市场竞争问题研究——以医药制造业上市公司为例